You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Digestive tract conditions
  5. Inflammatory bowel disease

Infliximab and adalimumab for the treatment of Crohn's disease

  • Technology appraisal guidance
  • Reference number: TA187
  • Published:  19 May 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Information for the public

  • Infliximab and adalimumab for Crohn’s disease (PDF 61 KB)

    Published:
    19 May 2010
  • Gwybodaeth i'r cyhoedd (Word 330 KB)

    Published:
    07 July 2010